Kotfis, K., Lechowicz, K., Drożdżal, S., Niedźwiedzka-Rystwej, P., Wojdacz, T. K., Grywalska, E., . . . Parczewski, M. (2021). COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection. Pharmaceuticals (Basel).
Chicago Style citaatKotfis, Katarzyna, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, Jowita Biernawska, Magda Wiśniewska, en Miłosz Parczewski. "COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-CoV-2 Infection." Pharmaceuticals (Basel) 2021.
MLA citatieKotfis, Katarzyna, et al. "COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-CoV-2 Infection." Pharmaceuticals (Basel) 2021.